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Paragangliomas are rare tumors originating outside of the adrenal medulla which can be associated with catecholamine secretion
or mass effect, one of which typically leads to their discovery. The differences between these tumors and traditional intra-adrenal
pheochromocytomas are a subject of recent investigations. Standard of care therapy is medical management and surgical resection
of the tumor.When tumors are biochemically active, medical optimization of the autonomic nervous system is a critical component
to a safe, definitive resection. Tumors arising in the retroperitoneum present technical challenges for the surgeon as they are often
large and difficult to access, making an oncologic resection much more difficult. Lastly, these tumors are mostly benign and rarely
invade adjacent structures—an operative finding not always predicted by preoperative imaging—which, if present, adds significant
complexity and risk to the resection. A case illustrating these challenges in themanagement of a biochemically active retroperitoneal
paraganglioma invading the inferior vena cava follows.
1. Introduction
Pheochromocytomas arise from chromaffin cells of the
adrenal medulla. They are often discovered clinically due
to their elaboration of catecholamines leading to a pre-
dictable symptomatology of tachycardia and/or palpations,
hypertension, sweating, and headaches. Cells of similar
embryologic origin include those of the sympathetic and
parasympathetic ganglia, the carotid and aortic bodies, and
the organs of Zuckerkandl. Tumors arising from these extra-
adrenal sites are denoted “paragangliomas” and the distinc-
tion from pheochromocytomas (intra-adrenal sympathetic
paragangliomas) is receiving due interest in the literature
regarding differential genetic predisposition, biochemical
activity, metastatic potential, and prognosis. Paragangliomas
do possess the capacity to release catecholamines similar to
pheochromocytomas, often prompting their discovery.These
tumors may arise in a wide array of locations and thus
may present with diverse symptoms of mass effect. Rare
retroperitoneal origins may result in tumors growing very
large, potentially compressing or even invading other organs
before discovery. One such case is presented here.
2. Case Report
A 45-year-old African-American female presented with chest
pain and shortness of breath associated with nausea, vom-
iting, headache, and diaphoresis. Admit vital signs were
consistent with hypertension which was being treated with
amlodipine and metoprolol. Two 24-hour urine collections
demonstrated vanillylmandelic acid 64, 56.6 (N: 2–7mcg/
24 hr); normetanephrine 8364, 7406 (N: 75–375mcg/24 hr);
norepinephrine 1857, 1644 (N: 15–80mcg/24 hr). CT scan
of the abdomen revealed a moderately enhancing, homo-
geneous retroperitoneal mass measuring 5.9 × 4.9 cm with
significant mass effect on neighboring structures and vas-
culature without appreciable invasion (Figure 1). A I-131
metaiodobenzylguanidine (MIBG) scan showed uptake at
the abdominal mass only. CT-guided biopsy revealed cells
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Figure 1: Paraganglioma (red arrow) visualized on computed tomography scan with IV contrast in coronal (a) and axial (b) planes without
definitive evidence of local invasion.
(a) (b)
(c) (d)
Figure 2: Paraganglioma demonstrated with hematoxylin and eosin staining at 2x magnification (a) and 10x magnification (b) revealing
characteristic well-defined “Zellballen” nest pattern of tumor cells bound by a delicate fibrovascular stroma. At 10x magnification,
immunohistochemical staining is positive for chromogranin (c) and synaptophysin (d). Images courtesy of Tulane University School of
Medicine, Department of Pathology.
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Figure 3: Paraganglioma shown at 10x magnification with Ki-67
staining demonstrating a low proliferative index. Image courtesy of
Tulane University School of Medicine, Department of Pathology.
Figure 4: Intraoperative photograph of paraganglioma retracted to
reveal vascular clamp about the underlying inferior vena cava. Image
courtesy of Tulane University School of Medicine, Department of
Endocrine Surgery.
with salt-and-pepper chromatin, abundant eosinophilic cyto-
plasm with a granular appearance, and classic Zellballen nest
pattern (Figures 2(a) and 2(b)). Immunohistochemical stain-
ing demonstrated positivity for chromogranin (Figure 2(c))
and synaptophysin (Figure 2(d)) with a low Ki-67 prolifer-
ative index (Figure 3). A diagnosis of retroperitoneal para-
ganglioma (extra-adrenal pheochromocytoma)was declared.
Patient was started on alpha blockade with prazosin.
Days prior to her surgical appointment, patient was
admitted for hypertensive urgency with a blood pressure
of 202/157 secondary to medication noncompliance due to
nausea. Blood pressure was controlled with combined alpha
and beta blockade; then patient was cleared for surgery.
Upon entering the abdomen, impressive dilated bowel was
noted secondary to mass compression. A dissection plane
between the retroperitoneal mass and the transverse colon,
duodenum, pancreas, and right kidneywas achieved. Because
the mass could not be separated from the inferior vena
cava (IVC), a vascular clamp was applied (Figure 4) and the
junction was resected en bloc. Four draining vessels were
ligated and immediately the patient converted from stable
hypertensive to hypotensive. The anesthesia team restored
normotension. The IVC was then reconstructed (Figure 5).
Feeding arteries were ligated and the mass was lifted from
Figure 5: Intraoperative photograph demonstrating reconstructed
inferior vena cava status after en bloc resection of attached para-
ganglioma. Image courtesy of TulaneUniversity School ofMedicine,
Department of Endocrine Surgery.
the aorta and freed. Several periaortic lymphnodeswere sam-
pled, bowel obstruction was ruled out, and the abdomen was
closed. Surgical pathology revealed a 7 cm paraganglioma
with IVC invasion, negative margins, and a single reactive
lymph node. As of last follow-up, patient remained asymp-
tomatic, normotensive, and without evidence of disease.
3. Conclusion
A 2001 retrospective review of 236 cases of benign para-
ganglioma by the Mayo Clinic provided data on these
rare neoplasms finding that the majority (69%) of these
tumors occurred in the head and neck. Just 21.5% were
abdominal and of those 38% were periaortic/pericaval, 20%
were perirenal, and 18% were at the organ of Zuckerkandl.
All patients with periaortic or pericaval masses who were
screened for catecholamine excess were discovered to have
hyperfunctioning tumors, 95% resulting in hypertension [1].
A 2010 review of 67 retroperitoneal paraganglioma cases
found similarly that 57% were periaortic (without further
specification) and 82% were hyperfunctional [2]. Our case
supports the data of periaortic paragangliomas typically
being hyperfunctional.
A retrospective review from Johns Hopkins focused on
retroperitoneal paragangliomas which comprised 22 of 253
(8.7%) paraganglioma resections. They documented average
size (7.4 cm), rate of metastasis (9.5%), and rate of bio-
chemical functionality (57.1%) [3]. Five-year overall survival
after resection was 73% with prognosis significantly worse
after metastasis, the rates of which were independent of
tumor diameter, functionality, surgical margin status, and
lymphnode involvement [3]. 41%of tumors required adjacent
organ resection, best predicted by a tumor size greater than
7 cm [3]; our case supports this conclusion. A 1990 study
from Memorial Sloan Kettering found complete resection
to be associated with 75% 5-year overall survival rate in
retroperitoneal paragangliomas, which in their study had a
rate of metastasis of 50% [4]. It has been documented that
neither histology nor local invasion can predict malignant
potential in these tumors, instead leaving metastasis as the
sole method of confirmation [4, 5].
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Accepted treatment for retroperitoneal paragangliomas
is resection with annual follow-up biochemical testing [6],
though this is limited by only a fraction of tumors being
biochemically functional [1–3]. Retroperitoneal tumors often
present with mass effects as discovered in our patient who
had several segments of dilated bowel due to compression
by the tumor. An additional complication is local invasion
into vascular structures such as the aorta or inferior vena
cava. Few cases exist in the literature of successful en bloc
resections of retroperitoneal paragangliomas that invaded
major vessels [7, 8]. One such case noted tight adhesion of the
tumor to the aorta and inferior vena cava [8] while another
suggested possible origin from the wall of the inferior vena
cava [7], the latter ruled out by surgical pathology in our case.
En bloc resection of many tumor types requiring vascular
reconstruction has been documented with vascular patency
rates at 24mos. of 90% [9] with acceptable levels of morbidity
andmortality confirmed in other studies [10]. Partial inferior
vena cava resection with reconstruction was achieved in our
patient and, as of last follow-up, vascular patency remained
preserved.
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